Targeting the DNA Damage Response for Anti-Cancer Therapy
Springer International Publishing AG, 2018
238,25 €On orderDelivery: 2-3 weeks
As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents thatmay have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR.
- ISBN-13
- 9783319758343
- ISBN-10
- 3319758349
- Publisher
- Springer International Publishing AG
- Year
- 2018
- Publication date
- 2018-06-05
- Pages
- 401
- Dimensions
- 235x155x